Article Details
Retrieved on: 2022-08-18 09:13:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Polish cancer drug developer, Ryvu Therapeutics, has received €22m funding from the European Investment Bank via its venture debt instrument.
Article found on: european-biotechnology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here